According to a press release from the U.S. attorney’s office, P&S Pharmacy and its owner, Lowell Grizzle, have agreed to pay the United States a $100,000 settlement regarding multiple record-keeping violations.
Federal prosecutors say these violations were discovered in November 2014 following an audit of P&S Pharmacy by the DEA.
Specifically, the United States alleged that P&S Pharmacy and Grizzle failed to maintain complete and accurate records with respect to several Schedule II controlled substances and failed to note the date and quantity of controlled substances that were received.
“Given the severity of the opioid crisis in East Tennessee, it is imperative that pharmacies maintain accountability by keeping accurate records and ensuring that prescribed opioids do not fall into the wrong hands,” said U.S. Attorney J. Douglas Overbey. “Retail pharmacists and other professionals who fail to fulfill their legal obligations to keep a responsible account of these dangerous drugs increases the risk of diversion, which contributes to this crisis.”
The claims resolved by the settlement are allegations only, and there has been no determination of liability.
ABOUT THE CONTROLLED SUBSTANCES ACT
In order to prevent the diversion or misuse of controlled substances, the Controlled Substances Act requires people and companies to maintain complete and accurate records relating to the controlled substances they receive and dispense.